Defining co-related parameters between ‘metabolic’ flare and ‘clinical’, ‘biochemical’, and ‘osteoblastic’ flare and establishing guidelines for assessing response to treatment in cancer Sandip BasuAbass Alavi Editorial 27 October 2006 Pages: 441 - 443
Nuclear medicine in the treatment of neuroendocrine tumours—problems and perspectives Tomasz GrzelaAgata BialoszewskaRobert Brawura-Biskupski-Samaha Editorial 30 November 2006 Pages: 444 - 447
Is MIBG a substrate of P-glycoprotein? Yasushi KiyonoTomoko YamashitaHideo Saji Original article 10 November 2006 Pages: 448 - 452
Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer Ursula NestleAndrea Schaefer-SchulerCarl-Martin Kirsch Original article 21 October 2006 Pages: 453 - 462
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer Susanne Martina EschmannGodehard FriedelRoland Bares Original article 14 November 2006 Pages: 463 - 471
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence Sandro SironiMaria PicchioFerruccio Fazio Original article 16 November 2006 Pages: 472 - 479
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings Hyun Hoon ChungWon Jun KangHyo-Pyo Lee Original article 07 November 2006 Pages: 480 - 486
Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality? Michael ZollerSusanne KohlfuerstPeter Lind Original article 14 November 2006 Pages: 487 - 495
Quantification of Parkinson’s disease-related network expression with ECD SPECT Thomas EckertKoen Van LaereDavid Eidelberg Original article 10 November 2006 Pages: 496 - 501
Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson’s disease: an [123I]IBZM and [123I]FP-CIT SPECT study C. C. P. VerstappenB. R. BloemM. W. I. M. Horstink Original article 20 October 2006 Pages: 502 - 507
Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease A. LokkegaardL. M. WerdelinL. Friberg Original article 10 November 2006 Pages: 508 - 516
A hybrid algorithm for PET/CT image merger in hybrid scanners John A. KennedyOra IsraelHaim Azhari Original article 10 November 2006 Pages: 517 - 531
Performance evaluation of the Philips MOSAIC small animal PET scanner Marc C. HuismanSybille RederMarkus Schwaiger Original article 22 November 2006 Pages: 532 - 540
Which thyroid cancer patients need periodic stimulation tests? Paolo Zanotti-FregonaraAlexandre KhouryElif Hindié Original article 14 November 2006 Pages: 541 - 546
Contemporary adrenal scintigraphy Milton D. GrossAnca AvramDomenico Rubello Occasional survey 25 November 2006 Pages: 547 - 557
Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction Anna Rita SorrentinoWanda AcampaAlberto Cuocolo Original Article 20 December 2006 Pages: 558 - 562
Simultaneous evaluation of myocardial blood flow, cardiac function and lung water content using [15O]H2O and positron emission tomography Alexandru NaumHelena TuunanenJuhani Knuuti Original article 24 October 2006 Pages: 563 - 572
Identification of advanced coronary artery disease with exercise myocardial perfusion imaging: the clinical value of a novel approach for assessing lung thallium-201 uptake Efstratios MoralidisTryfon SpyridonidisConstantinos Anagnostopoulos Original article 23 November 2006 Pages: 573 - 583
Stress-induced abnormalities in myocardial perfusion imaging that are not related to perfusion but are of diagnostic and prognostic importance John P. HigginsJohanna A. HigginsGethin Williams Review Article 14 November 2006 Pages: 584 - 595
How early? ASAP: molecular and functional imaging! Giovanni Lucignani Focus on ... 17 February 2007 Pages: 596 - 601
Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy Omgo NiewegRenato Valdés Olmos Letter to the editor 05 January 2007 Pages: 602 - 602
Reply Janne HornJørgen Lock-AndersenAnnika Loft Letter to the editor 05 January 2007 Pages: 603 - 603
Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites? Sandip BasuAbass Alavi Letter to the editor 06 January 2007 Pages: 604 - 605
Is it possible to predict renal function in small animals using a multi-pinhole SPECT system? Emmanuel DurandPhilippe Chaumet-RiffaudAlain Prigent Letter to the editor 13 January 2007 Pages: 606 - 606
Role of 99mTc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery Theodore Athanasoulis Letter to the editor 16 January 2007 Pages: 607 - 608
Myocardial perfusion imaging with a novel SPECT/CT system: all that glitters is not gold Jyrki T. Kuikka Letter to the editor 18 January 2007 Pages: 611 - 612
A simplified analysis of [18F]3′-deoxy-3′-fluorothymidine metabolism and retention Anthony F. ShieldsDavid A. BristonOtto Muzik Erratum 09 January 2007 Pages: 613 - 613
False positive 18F-FDG PET/CT due to gynaecomastia R. RamtahalsingA. I. J. ArensR. G. H. Beets-Tan Image of the month 25 November 2006 Pages: 614 - 614
Visualization of five hyperplastic parathyroid glands using 99mTc-sestamibi scintigraphy in a patient with chronic renal failure Khaled AlkhawaldehGonca BuralAbass Alavi Image of the month 14 November 2006 Pages: 615 - 615
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin) Jan TennvallManfred FischerBoudewijn Brans Guidelines 24 February 2007 Pages: 616 - 622
Certificate of Fellowship of the European Board of Nuclear Medicine 2007 Society communication 07 March 2007 Pages: 623 - 624